ActoGeniX N.V. logo — company profile

ActoGeniX N.V.

Founded 2006 Belgium Belgium 5 employees Private Equity Biopharma, Biotechnology +1

General Information

Company Name ActoGeniX N.V.
Founded Year 2006
Location Belgium Belgium +1
Employees 5
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Private Equity
Social

Get notified when ActoGeniX N.V. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ActoGeniX N.V.

ActoGeniX N.V. is a biopharmaceutical company based in Belgium, founded in 2006. The company is dedicated to the development and commercialization of a groundbreaking class of biological drugs called ActoBiotics™. These innovative drugs are created using TopAct™, ActoGeniX’s proprietary technology platform, and are designed for oral administration to target receptors and pathways in gastrointestinal tissues. ActoBiotics™ have the potential to address a wide range of severe diseases, with a particular focus on areas with unmet needs in gastrointestinal, immunological, and metabolic diseases. With several ActoBiotics™ currently in various stages of clinical and preclinical development, ActoGeniX is poised to make a significant impact in the field of biopharmaceuticals. Although specific details about the latest investment and the investors are not available at the moment, the company's innovative approach and promising pipeline make it an intriguing prospect for potential investors looking to enter the biopharmaceutical and biotechnology sectors.

No funding data available for ActoGeniX N.V. yet.

Get notified when ActoGeniX N.V. raises funding

ActoGeniX N.V. Alternatives & Competitors

ActoGeniX N.V. vs

Innovating therapeutic solutions for gastrointestinal diseases and unmet patient needs worldwide

Series B
Biotechnology, Health Care
ActoGeniX N.V. vs

RedHill (NASDAQ: RDHL): a pharmaceutical company focused on proprietary drugs for GI and infectious...

Post Ipo Equity
55 employees
Biotechnology, Health Care
ActoGeniX N.V. vs

Center for Digestive Disease is a gastroenterology clinic specializing in the prevention, diagnosis,...

25 employees
Health Care

FAQ About ActoGeniX N.V.

ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics™. ActoBiotics™ are created using TopAct™, ActoGeniX’s versatile and proprietary technology platform. They can be orally administered and target receptors a...
ActoGeniX N.V. was founded in 2006.
ActoGeniX N.V. is headquartered in Belgium.
ActoGeniX N.V. operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
ActoGeniX N.V. has approximately 5 employees.
Top alternatives and competitors to ActoGeniX N.V. include Atlantic Healthcare, RedHill Biopharma Ltd., Center For Digestive Disease, Optimer Pharmaceuticals, SmartPill. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ActoGeniX N.V. and Atlantic Healthcare are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ActoGeniX N.V. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes